前臨床CROの世界市場レポート 2024年

前臨床CRO市場規模は近年力強く成長しています。2023年の51億5,000万米ドルから2024年には56億6,000万米ドルへと、CAGR9.9％で拡大します。この成長は、医薬品開発の加速化、コスト抑制戦略の採用、コアコンピタンスへの戦略的集中、規制遵守要件の順守、臨床試験のグローバリゼーションなど、さまざまな要因によるものです。

前臨床試験に対する需要の増加は、近い将来、前臨床試験受託機関（CRO）市場の拡大を促進すると予想されます。前臨床試験とは、ヒトのボランティアが被験者となる前に行われる治療法や治療法の研究を指します。革新的な医療機器、処方薬、診断薬を含むこれらの調査は、ファースト・イン・ヒト研究のための安全な初期投与量を確立し、潜在的な製品の毒性を評価することを目的としています。医薬品開発における前臨床試験の重要性は、新興医薬品の安全性と有効性への関心の高まりに後押しされ、ますます高まっています。2023年4月現在、国立医学図書館は、2021年末までに39万9,501件の前臨床試験が実施され、2022年末までに43万7,536件の前臨床試験が完了したと報告しており、前臨床試験に対する需要の高まりとその結果としての前臨床CRO市場への影響が浮き彫りになっています。

2023年の前臨床CRO市場で最大の地域は北米でした。アジア太平洋は予測期間中、世界の前臨床CRO市場で最も急成長する地域となる見込みです。前臨床CRO市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の前臨床CRO市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の前臨床CRO市場規模実績と成長率、2018～2023年
• 世界の前臨床CRO市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の前臨床CRO市場、サービス別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 生物分析とDMPK研究
• 毒性試験
• 化合物管理
• 化学
• 安全性薬理学
• その他のサービス
• 世界の前臨床CRO市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 患者由来オルガノイド（PDO）モデル
• 患者由来異種移植片モデル
• 世界の前臨床CRO市場、動物モデル別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 小型動物モデル
• 大型動物モデル
• 世界の前臨床CRO市場、モデルシステム別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• In Vivo
• In Vitro
• 世界の前臨床CRO市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• バイオ医薬品企業
• 政府と学術機関
• 医療機器企業
• その他のエンドユーザー

第7章 地域と国の分析

• 世界の前臨床CRO市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の前臨床CRO市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 前臨床CRO市場の競合情勢
• 前臨床CRO市場の企業プロファイル
  • Eurofins Scientific SE
  • PRA Health Sciences Inc.
  • Wuxi AppTec Co. Ltd.
  • Medpace Holdings Inc.
  • Charles River Laboratories International Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

“Preclinical CRO Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on preclinical crow market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for preclinical crow? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The preclinical crow market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Service: Bioanalysis And DMPK Studies; Toxicology Testing; Compound Management; Chemistry; Safety Pharmacology; Others Services
• 2) By Type: Patient Derived Organoid (PDO) Model; Patient Derived Xenograft Model
• 3) By Animal Model: Small Animal Model; Large Animal Model
• 4) By Model System: In Vivo; In Vitro
• 5) By End User: Biopharmaceutical Companies; Government And Academic Institutes; Medical Device Companies; Other End-users
• Companies Mentioned: Eurofins Scientific SE; PRA Health Sciences Inc.; Wuxi AppTec Co. Ltd.; Medpace Holdings Inc.; Charles River Laboratories International Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Preclinical Contract Research Organizations (CROs) play a crucial role as indispensable support entities, providing essential expertise in research and development to guide drug candidates through the animal testing phase and advance them toward the clinical stage. Their significance lies in aiding medical product producers in demonstrating the safety and efficacy of their products in animals that closely mimic human anatomy, adhering to FDA standards. This process is a prerequisite before initiating clinical trials or human applications.

The services offered by preclinical CROs cover a wide spectrum, including bioanalysis and DMPK studies, toxicology testing, compound management, chemistry, safety pharmacology, and more. A notable advancement in this domain is the adoption of patient-derived organoids (PDOs), which are small three-dimensional cell cultures created from a patient's cancer cells. Substantial investments and experimental validation efforts have been dedicated to PDOs, presenting promising therapeutic alternatives for diagnosing complex diseases. The repertoire of preclinical CRO services encompasses various models, such as the patient-derived organoid (PDO) model and patient-derived xenograft model, applicable to both small and large animal models. These model systems, spanning In Vivo and In Vitro approaches, find applications among biopharmaceutical companies, government and academic institutes, medical device companies, and other stakeholders.

The preclinical CRO market research report is one of a series of new reports from The Business Research Company that provides preclinical CRO market statistics, including preclinical CRO industry global market size, regional shares, competitors with an preclinical CRO market share, detailed preclinical CRO market segments, market trends and opportunities, and any further data you may need to thrive in the preclinical CRO industry. This preclinical CRO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The preclinical cro market size has grown strongly in recent years. It will grow from $5.15 billion in 2023 to $5.66 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth observed in the historical period can be attributed to various factors, including a rising demand for accelerated drug development, the adoption of cost containment strategies, a strategic focus on core competencies, adherence to regulatory compliance requirements, and the globalization of clinical trials.

The preclinical cro market size is expected to see strong growth in the next few years. It will grow to $7.94 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The projected growth in the forecast period is associated with several factors, particularly the rising significance of personalized medicine, an increased focus on addressing rare diseases and orphan drugs, a surge in outsourcing within the biopharmaceutical sector, a dedicated emphasis on biomarker research, and a growing demand for the generation of real-world evidence. Key trends expected to shape this period include the integration of artificial intelligence (AI), the proliferation of oncology research, advancements in omics technologies, progress in advanced in vitro and in vivo models, and collaborative efforts in translational research.

The increasing demand for preclinical trials is expected to drive the expansion of the preclinical Contract Research Organization (CRO) market in the near future. Preclinical trials involve studies conducted on medicinal treatments or therapies before human volunteers become test subjects. These studies, which include innovative medical devices, prescription medications, and diagnostics, aim to establish a safe initial dosage for first-in-human research and evaluate potential product toxicity. The significance of preclinical trials in drug development is growing, propelled by a heightened focus on the safety and efficacy of emerging drugs. As of April 2023, the National Library of Medicine reported 399,501 preclinical studies conducted by the end of 2021 and 437,536 preclinical trials completed by the end of 2022, highlighting the escalating demand for preclinical trials and its consequential impact on the preclinical CRO market.

The increasing need for outsourcing services is poised to be a driving force behind the growth of the preclinical CRO market in the coming years. Outsourcing services involve contracting with third-party vendors to manage specific business tasks or operations. The complexity of preclinical research is on the rise, requiring specialized skills and expertise not always available in-house for pharmaceutical and biotechnology companies. Outsourcing to preclinical CROs allows companies to access the necessary expertise without the burden of building internal capabilities, enabling them to focus on core business activities while ensuring the completion of preclinical research. In April 2023, a survey by BioPlan Associates Inc. revealed that 84.6% of biomanufacturers are outsourcing analytical testing, and 74.5% are outsourcing toxicity testing in 2023. This underscores the increasing reliance on outsourcing services, contributing to the upward trajectory of the preclinical CRO market.

Technological advancements are a prominent trend gaining momentum in the preclinical Contract Research Organization (CRO) market, with significant companies in the sector adopting innovative technologies to strengthen their market positions. In February 2023, BenchSci, a Canada-based AI solutions company specializing in preclinical Research and Development (R&D), introduced ASCEND, an end-to-end Software as a Service (SaaS) platform for preclinical drug discovery. Leveraging artificial intelligence, ASCEND accelerates the preclinical phase of drug development pipelines by deriving biological insights into the foundational aspects of diseases. BenchSci's machine learning technology is employed to extract experimental data from both internal and external sources, enabling a comparison of results using curated ontology datasets. This approach facilitates the creation of evidence-based maps illustrating the biological processes underlying various diseases.

Key players in the preclinical CRO landscape are actively engaging in collaborations and partnerships to enhance their service offerings. Strategic partnerships, characterized by structured affiliations through business agreements or contracts, are a focal point in this context. In February 2022, IonsGate Preclinical Services Inc., a Canada-based CRO specializing in preclinical research services, announced a partnership with Insilicotrials Technologies Srl, an Italy-based provider of specialized consultancy for clinical trial solutions. This collaborative effort aims to leverage innovative technologies to expedite drug discovery processes, enabling more comprehensive preclinical testing capable of identifying potential safety risks at earlier stages of development.

In June 2022, Asahi Kasei Medical Co. Ltd., a Japan-based chemical company, successfully completed the acquisition of Bionova Scientific, LLC, in an undisclosed transaction. This strategic acquisition enhances Asahi Kasei Medical's bioprocess business by integrating a biopharmaceutical Contract Development and Manufacturing Organization (CDMO). The move broadens their customer base, particularly among those engaged in the development of cutting-edge next-generation biopharmaceuticals. Bionova Scientific LLC, a US-based company, specializes in offering contract process development services and Good Manufacturing Practice (GMP)-compliant contract manufacturing services for biopharmaceutical firms.

Major companies operating in the preclinical cro market report are Eurofins Scientific SE, PRA Health Sciences Inc., Wuxi AppTec Co. Ltd., Medpace Holdings Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, SGA SA, Intertek Group plc, Crown Bioscience International, Cynbiose, AmplifyBio LLC, Vivotecnia SL, Simavita Ltd., BioEmission Technology Solutions, Altasciences Company Inc., Global Center For Medical Innovation, Pharmaceutical Product Development LLC, Parexel International Corporation, Envigo RMS Holding Corporation, Veeda Clinical Research Ltd., ICON plc, Kunming Biomed International Ltd., PharmaLegacy Laboratories, NorthEast BioAnalytical Laboratories LLC, MDS Pharma Services, MPI Research, Toxikon Corporation, BioReliance Corporation, Covance Inc., Syngene International Limited

North America was the largest region in the preclinical CRO market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global preclinical CRO market during the forecast period. The regions covered in the preclinical cro market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the preclinical cro market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The preclinical CRO market includes revenues earned by entities through project management, information gathering, medical evaluations, maximum dose research, adherence to regulations, efficacy and safety reporting, and quality analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Preclinical CRO Market Characteristics

3. Preclinical CRO Market Trends And Strategies

4. Preclinical CRO Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Preclinical CRO Market Size and Growth

• 5.1. Global Preclinical CRO Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Preclinical CRO Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Preclinical CRO Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Preclinical CRO Market Segmentation

• 6.1. Global Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Bioanalysis And DMPK Studies
• Toxicology Testing
• Compound Management
• Chemistry
• Safety Pharmacology
• Others Services
• 6.2. Global Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Patient Derived Organoid (PDO) Model
• Patient Derived Xenograft Model
• 6.3. Global Preclinical CRO Market, Segmentation By Animal Model, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Small Animal Model
• Large Animal Model
• 6.4. Global Preclinical CRO Market, Segmentation By Model System, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• In Vivo
• In Vitro
• 6.5. Global Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Biopharmaceutical Companies
• Government And Academic Institutes
• Medical Device Companies
• Other End-users

7. Preclinical CRO Market Regional And Country Analysis

• 7.1. Global Preclinical CRO Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Preclinical CRO Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Preclinical CRO Market

• 8.1. Asia-Pacific Preclinical CRO Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Preclinical CRO Market

• 9.1. China Preclinical CRO Market Overview
• 9.2. China Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Preclinical CRO Market

• 10.1. India Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Preclinical CRO Market

• 11.1. Japan Preclinical CRO Market Overview
• 11.2. Japan Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Preclinical CRO Market

• 12.1. Australia Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Preclinical CRO Market

• 13.1. Indonesia Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Preclinical CRO Market

• 14.1. South Korea Preclinical CRO Market Overview
• 14.2. South Korea Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Preclinical CRO Market

• 15.1. Western Europe Preclinical CRO Market Overview
• 15.2. Western Europe Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Preclinical CRO Market

• 16.1. UK Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Preclinical CRO Market

• 17.1. Germany Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Preclinical CRO Market

• 18.1. France Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Preclinical CRO Market

• 19.1. Italy Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Preclinical CRO Market

• 20.1. Spain Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Preclinical CRO Market

• 21.1. Eastern Europe Preclinical CRO Market Overview
• 21.2. Eastern Europe Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Preclinical CRO Market

• 22.1. Russia Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Preclinical CRO Market

• 23.1. North America Preclinical CRO Market Overview
• 23.2. North America Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Preclinical CRO Market

• 24.1. USA Preclinical CRO Market Overview
• 24.2. USA Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Preclinical CRO Market

• 25.1. Canada Preclinical CRO Market Overview
• 25.2. Canada Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Preclinical CRO Market

• 26.1. South America Preclinical CRO Market Overview
• 26.2. South America Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Preclinical CRO Market

• 27.1. Brazil Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Preclinical CRO Market

• 28.1. Middle East Preclinical CRO Market Overview
• 28.2. Middle East Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Preclinical CRO Market

• 29.1. Africa Preclinical CRO Market Overview
• 29.2. Africa Preclinical CRO Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Preclinical CRO Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Preclinical CRO Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Preclinical CRO Market Competitive Landscape And Company Profiles

• 30.1. Preclinical CRO Market Competitive Landscape
• 30.2. Preclinical CRO Market Company Profiles
  • 30.2.1. Eurofins Scientific SE
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. PRA Health Sciences Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Wuxi AppTec Co. Ltd.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Medpace Holdings Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Charles River Laboratories International Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Preclinical CRO Market Competitive Benchmarking

32. Global Preclinical CRO Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Preclinical CRO Market

34. Preclinical CRO Market Future Outlook and Potential Analysis

• 34.1 Preclinical CRO Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Preclinical CRO Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Preclinical CRO Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer